NAUT
Nautilus Biotechnology, Inc.
1.96$
+24.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Nautilus Biotechnology, Inc. (NAUT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -238 | -0.1 | -0.1 | -0.1 | -0.1 | -2.6 | -3.3 | -3.4 | -4.7 | -6.3 | -14 | -14 | -11 | -12 | -14 | -9.6 | -10 | -13 | -14 | -12 | -14 | -16 | -15 | -13 | -14 | -14 | -13 | -11 | -12 | -13 | -14 | -50 | |
| – | – | – | – | – | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.3 | 0.7 | 0.9 | 0.8 | 0.8 | 0.9 | 0.9 | 1.2 | 1.5 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.5 | 1.3 | 6.0 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.1 | 0.3 | 1.3 | 1.8 | 2.2 | 2.5 | 2.1 | 2.6 | 2.9 | 2.8 | 2.9 | 3.1 | 3.1 | 3.1 | 3.1 | 3.3 | 3.2 | 3.1 | 2.2 | 1.7 | 1.5 | 1.5 | 1.4 | 1.2 | 5.5 | |
| – | – | – | – | – | 0.1 | 0.1 | 0.2 | – | 1.5 | 1.9 | 2.2 | 2.7 | 2.1 | 2.6 | 2.9 | 2.8 | 2.9 | 3.1 | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.7 | -0.2 | -0.1 | -0.2 | -0.4 | -0.3 | -0.5 | -0.1 | -0.3 | 0.1 | -1.5 | -2.6 | 2.6 | 0.5 | -2.1 | 1.0 | -0.2 | -0.9 | -1.6 | 0.2 | -0.9 | -1.5 | -1.6 | -0.7 | -1.6 | -0.6 | -1.2 | -0.3 | -1.5 | -1.2 | -1.8 | -4.7 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.3 | 0.3 | 0.5 | 1.0 | 0.3 | 1.0 | 0.5 | 0.7 | 1.0 | 0.2 | 0.7 | 0.5 | 0.9 | 0.4 | 0.6 | 0.5 | 0.7 | 0.3 | 0.2 | 0.4 | 0.4 | 0.2 | 0.5 | 0.5 | 1.6 | |
| 1.2 | – | – | – | 1.2 | 7.9 | -46 | -16 | 29 | 24 | -61 | -84 | 6.1 | 15 | 35 | -12 | -64 | -13 | -2.3 | 13 | -41 | 22 | 14 | -7.5 | 37 | 20 | 14 | 0.5 | 0.8 | 14 | 12 | 27 | |
| – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.2 | -1.1 | 0.1 | 0.1 | 0.1 | -0.7 | – | 154 | 0.7 | 0.7 | -8.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.0 | 0.1 | – | 0.3 | – | – | 0.3 | – | – | 0.1 | 0.1 | 0.0 | – | – | – | |
| 145,187 | 145,187 | – | – | – | -2.1 | 76 | 0.0 | 0.0 | -2.1 | 327 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.3 | 0.2 | 0.3 | 0.1 | 0.4 | 0.0 | 0.1 | 0.0 | 0.1 | 1.1 | 0.2 | 1.5 | |
| 1.2 | -0.1 | -0.1 | -0.1 | 1.1 | -868 | 27 | -20 | 24 | 15 | 288 | -98 | -4.6 | 3.0 | 22 | -21 | -74 | -26 | -16 | 1.4 | -55 | 6.3 | -0.8 | -20 | 23 | 5.6 | 1.2 | -11 | -11 | 2.2 | -1.5 | -21 | |
| -238 | -0.1 | -0.1 | -0.1 | -0.1 | -2.7 | -3.5 | -3.6 | -5.0 | -6.7 | -15 | -14 | -12 | -13 | -14 | -11 | -11 | -13 | -14 | -13 | -14 | -17 | -16 | -14 | -15 | -14 | -14 | -11 | -13 | -14 | -14 | -52 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.